ACME Solar Secures $164.0M Funding

EIT Pharma, Inc.

EIT Pharma is a biotechnology company based in Kirkland, Washington, focused on developing therapies for patients with serious viral diseases. In addition to lonafarnib for chronic hepatitis D, the company has obtained rights to lambda, which is being developed for severe acute viral respiratory tract infections. EIT Pharma was established by experienced clinical and biotechnology leaders to identify and advance overlooked or underdeveloped assets. At EIT Pharma, our focus is on advancing therapies where the unmet need is high, the science is rigorous, and the potential impact on patients is meaningful.

Able Labs

Founded in 2024, Able Labs is building the next evolution of DeFi with a permissionless, decentralized protocol across multiple chains. Our mission is to bring back cypherpunks ethos, solve asset abstraction, and provide users with visceral experiences. By enabling a more fluid and efficient movement of assets across networks, we are helping to push the entire space forward. Able Labs provides a more intuitive, transparent, and scalable approach to asset management—bridging the gap between institutional finance and decentralized ecosystems. Able Labs was founded by a team of seasoned leaders with deep expertise in strategy, technology, and product development. Together, we are redefining on-chain asset management, unlocking new opportunities for seamless asset trading and tokenization. Anyone Able to DeFi.